Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 17/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.80 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28292886 | 0.89 | PTGS2 (1.00) | PTGS2CHRNA7MEN1MAPTKMT2A | |
| SCHEMBL28294491 | 0.89 | PTGS2 (1.00) | PTGS2PTGS1CHRNA7CYP2C9 | |
| SCHEMBL28292993 | 0.87 | PTGS2 (1.00) | PTGS2CHRNA7MEN1MAPTKMT2A | |
| SCHEMBL28292890 | 0.87 | PTGS2 (1.00) | PTGS2CHRNA7MEN1MAPTKMT2A | |
| SCHEMBL28872997 | 0.87 | PTGS2 (1.00) | PTGS2PTGS1CHRNA7MEN1MAPT | |
| SCHEMBL28292903 | 0.85 | PTGS2 (1.00) | PTGS2CHRNA7 | |
| SCHEMBL28292893 | 0.83 | PTGS2 (1.00) | PTGS2PTGS1CHRNA7MEN1MAPT | |
| SCHEMBL28294492 | 0.83 | CHRNA7 (0.77) | PTGS2PTGS1CHRNA7CYP2C9 | |
| SCHEMBL28292892 | 0.83 | PTGS2 (1.00) | PTGS2PTGS1CHRNA7 | |
| SCHEMBL3103035 | 0.81 | PTGS2 (0.80) | PTGS2PTGS1CHRNA7MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109748872-A | The design and synthesis of the morpholine derivative antitumoral compounds of one kind skeleton containing diaryl pyrazole | 南京大学 | 2019-05-14 | — | — | CN | disclosed |